Rapport Therapeutics, Inc. (RAPP) Capital expenditures 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$616,000FY2025 · since FY2023: $1.6M → $616,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $616,000 | -74.4% |
| FY2024 | $2.4M | +47.0% |
| FY2023 | $1.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice